Development and internal validation of a clinical prediction model for individualized dosing of BAY 81-8973, A full-length recombinant factor VIII, in pediatric patients with haemophilia A
- Resource Type
- Article
- Source
- In
Thrombosis Research December 2023 232:6-14 - Subject
- Language
- ISSN
- 0049-3848